Evidence map›Paper›PMID 41546713›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Impact of short-term efficacy after conservative treatment of bowel obstruction on long-term survival of patients with malignant tumors of the digestive system.

Le Tian, Jia-Xin Huang, Xi Zhang, Yang-Yang Cui, Na Li, Xin-Qi Liu, Zhi-Yong Li, Qing-Long Jiang, Chao Wang, Wen-Jie Zhu and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Le Tian *Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jia-Xin Huang *Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xi Zhang *Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang-Yang CuiDepartment of Oncology, Nanpi County People's Hospital, Cangzhou, China.
Na LiDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xin-Qi LiuDepartment of Traditional Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhi-Yong LiDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qing-Long JiangDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chao WangDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wen-Jie ZhuDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bao-Hua ZouDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen-Xin SongDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Rong QinDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xin-Yi WangDepartment of Medicine, Gesi (Hebei) Medical Research Institute, Langfang, Hebei, China.
Jin QinDepartment of Clinical Nutrition, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Shao-Ming WangNational Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zong-Jin LiuDepartment of Hematology and Oncology, Shanxi Provincial Coal Central Hospital, Taiyuan, China.
Guo-Yan GeDepartment of Oncology, Changzhi Traditional Chinese Medicine Hospital, Changzhi, China.
Lei YuDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ning LiDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. mzbgd_0@sina.com.
Ming-Hua CongDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. congmh@cicams.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of short-term bowel obstruction outcomes on the long-term survival of patients with digestive system malignancies and bowel obstruction after conservative management.

methodsClinical information, treatment methods, and outcomes of 110 patients with digestive system malignant tumors (gastric cancer, colorectal cancer, and hepatobiliary pancreatic cancer) complicated with bowel obstruction were collected retrospectively. Survival of the patients was determined to observe the impact of short-term outcomes following bowel obstruction treated conservatively, on long-term survival.

resultsThe median age of the 110 patients with digestive system malignancies complicated by bowel obstruction was 60 years (range: 31-86 years). The median time from diagnosis of digestive malignancy to the development of bowel obstruction was 5.5 months (range: 1.0-22.2 months). The rate of ileus relief with conservative management was 76.4% (84/110), and the median treatment duration was 4 days (range: 2-8 days). Hemoglobin, lymphocyte count, and albumin levels were lower, but the C-reactive protein (CRP) level was higher in patients with unrelieved bowel obstruction after conservative management (P < 0.05). Staging (odds ratio [OR] = 7.847, P = 0.03), previous chemotherapy (OR = 0.127, P = 0.002), previous radiotherapy (OR = 23.076, P = 0.003), and CRP level (OR = 17.788, P = 0.042) were independent risk factors for failure of remission from obstruction by conservative management. The median follow-up period was 35 months, and the median survival time was 40.0 months. The median survival time of patients with relief from bowel obstruction managed conservatively was longer than that of those without relief of obstruction (49 vs. 16 months, P = 0.023). Multivariate analysis suggested that stage III-IV and previous tumor surgery were independent factors for survival in patients of digestive system malignancies with bowel obstruction (hazard ratio [HR] = 2.847, 95% CI 1.024-7.912, P = 0.045; HR = 0.377, 95% CI 0.199-0.716, P = 0.003, respectively).

conclusionShort-term outcome of pharmacological conservative treatment after bowel obstruction in malignant tumors of the digestive system influences patients' long-term survival but is not an independent prognostic factor. Staging and previous tumor surgery are independent prognostic factors influencing survival in patients with malignancies of the digestive system combined with bowel obstruction.

Indexed as

Conservative TreatmentDigestive System NeoplasmsIntestinal ObstructionAdultAgedAged, 80 and overC-Reactive ProteinFemaleHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesSurvival RateTime FactorsTreatment OutcomeC-Reactive ProteinBowel obstructionColorectal cancerConservative managementGastric cancerRemissionSurvival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.